The Healing Company Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HLCO research report →
Price Chart
About the company
The Healing Company Inc. currently lacks significant business operations. In the past, its efforts were concentrated on the acquisition, exploration, and development of valuable natural resource properties.
- CEO
- Wanja Soren Oberhof
- IPO
- 2019
- Employees
- 20
- HQ
- New York City, NV, US
Get TickerSpark's AI analysis on HLCO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $23.28K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- -0.18
- Div Yield
- 0.00%
- Gross Margin
- 22.37%
- Op Margin
- -272.49%
- Net Margin
- -239.56%
- ROE
- -1025.52%
- ROIC
- -751.80%
Latest fiscal year · YoY change
- Revenue
- $8.89M+0.0%
- Gross Profit
- $1.99M+0.0%
- Op Income
- $-24,238,000
- Net Income
- $-21,309,000-18699.8%
- EPS
- $-0.42-16053.8%
- OCF Growth
- -202.7%
- FCF Growth
- -215.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.73
- RSI (14)
- 0
- Avg Volume
- 1.71K
No earnings-call transcripts are available for HLCO yet.
- Free Float
- 71.6%
- Shares Outstanding
- 58.19M
- Float Shares
- 41.64M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 18, 23 | Argyropoulos Demetrios Elias | sell | 50,000 |
| Jun 30, 23 | Argyropoulos Demetrios Elias | other | 0 |
| May 30, 23 | Argyropoulos Demetri | sell | 500,000 |
| Oct 18, 23 | Argyropoulos Demetri | sell | 500,000 |
| Oct 18, 23 | Argyropoulos Demetri | sell | 50,000 |
| Oct 25, 23 | Argyropoulos Demetri | buy | 125,000 |
| Oct 18, 23 | Argyropoulos Demetri | sell | 500,000 |
| Oct 18, 23 | Argyropoulos Demetri | sell | 62,500 |
| Oct 18, 23 | Argyropoulos Demetri | sell | 25,000 |
| Jun 30, 23 | Argyropoulos Demetri | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HLCO coverage
Recent articles, reports, and earnings notes.
No research on HLCO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HLCO report →AVITA Medical Reports Complete Cohealyx I Data in Full-Thickness Wounds Showing Earlier Graft Readiness and Six-Month Healing Outcomes
globenewswire.com · Nov 16
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
prnewswire.com · Sep 3
Synbio International Commences Revenue-Generating Operations With Launch of Healing Force™ Nutraceutical Division
thenewswire.com · Aug 11
2 Stocks Positioned for the Rise as AI Self‑Healing Systems Move From Concept to Core Infrastructure
247wallst.com · Aug 7
FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
globenewswire.com · Jun 22
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
globenewswire.com · Jun 12
FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
globenewswire.com · May 4
Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment
globenewswire.com · Apr 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.